ClinConnect ClinConnect Logo
Search / Trial NCT07020273

CONNECT Cancer Survivors With Tobacco Treatment

Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Jun 5, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Patient Reported Outcomes Tobacco Treatment

ClinConnect Summary

The Cancer Prevention by Reducing Tobacco Trial is studying how to help people stop using tobacco and improve their chances of quitting smoking. The trial will compare two different methods: one that uses reminders and encouragement (called nudges) to motivate people to change their tobacco use, and another that focuses on traditional quit methods, like medications and counseling. The goal is to find out which approach is more effective in helping people quit smoking and reduce their risk of cancer.

To take part in this trial, you need to be at least 18 years old, currently using tobacco, and receiving care at a clinic that is part of the study. If you join, you can expect to receive support and resources aimed at helping you quit smoking. This trial is not yet recruiting participants, but it aims to gather important information that could help many people improve their health by quitting tobacco.

Gender

ALL

Eligibility criteria

  • Eligibility Criteria:
  • Be receiving care at a participating clinic
  • Report current tobacco use (assessed by the rooming staff during the index visit)
  • Have a completed appointment with a participating clinic
  • Be an adult (at least 18 years old).

About Washington University School Of Medicine

Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.

Locations

Saint Louis, Missouri, United States

Patients applied

0 patients applied

Trial Officials

Li-Shiun Chen, M.D., MPH, ScD

Principal Investigator

Washington University School of Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported